Want to see VEEV full AI Analyst Report?
VEEV Stock Chart & Stats
$167.95
$3.27(1.54%)
At close: 4:00 PM EST
$167.95
$3.27(1.54%)
Day’s Range― - ―
52-Week Range$148.05 - $310.50
Previous CloseN/A
Volume260.89K
Average Volume (3M)2.27M
Market Cap
$31.74B
Enterprise Value$18.68K
Total Cash (Recent Filing)$7.31B
Total Debt (Recent Filing)$103.07M
Price to Earnings (P/E)33.9
Beta0.83
Next Earnings
Sep 02, 2026EPS Estimate
2.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.76
Shares Outstanding162,443,300
10 Day Avg. Volume1,665,818
30 Day Avg. Volume2,265,400
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)4.63
Price to Sales (P/S)10.44
P/FCF Ratio24.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$238.45Price Target Upside41.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering22
EPS Forecast (FY)9.06
Revenue Forecast (FY)$3.65B
Bulls Say, Bears Say
Bulls Say
Recurring Subscription RevenueA subscription-heavy model tied to mission-critical life‑sciences workflows produces durable, predictable revenue and high customer retention. Multi-year contracts and module expansion create steady cash streams and high switching costs, supporting long-term revenue visibility and upsell economics.
High And Sustainable MarginsElevated gross and net margins reflect scalable SaaS economics and specialized life‑sciences products (Vault, CRM, Data Cloud). These margins provide room to fund R&D, sales expansion, and strategic initiatives while preserving operating leverage over the medium term as product adoption grows.
Exceptionally Conservative Balance SheetExtremely low leverage gives strong financial flexibility to invest in product development, pursue bolt‑on M&A (e.g., Ostro), or endure macro stress without solvency pressure. A conservative balance sheet lowers refinancing risk and supports sustained strategic optionality over several quarters.
Bears Say
Revenue Growth SlowdownA marked deceleration to low single‑digit TTM growth weakens the company's growth runway relative to prior mid‑teens expansion. Slower top‑line momentum constrains operating leverage potential, raises pressure to accelerate product-led expansion, and increases dependence on cross‑sell and M&A to sustain growth.
Poor Free Cash Flow ConversionA steep drop in FCF conversion reduces internally available capital despite reported profits. Lower FCF limits flexibility for buybacks, debt reduction, or opportunistic M&A and may signal elevated working capital, one‑off items, or investment intensity that could persist while scaling new offerings.
Early-stage AI Execution RiskAI initiatives (Vault AI, Falcon) are promising but nascent; monetization is limited near term and commercial scaling requires data, regulatory proofs, and integration effort. Execution risk and compliance hurdles in life‑sciences may delay meaningful revenue and strain implementation resources over multiple quarters.
Veeva Systems News
VEEV FAQ
What was Veeva Systems Inc’s price range in the past 12 months?
Veeva Systems Inc lowest stock price was $148.05 and its highest was $310.50 in the past 12 months.
What is Veeva Systems Inc’s market cap?
Veeva Systems Inc’s market cap is $31.74B.
When is Veeva Systems Inc’s upcoming earnings report date?
Veeva Systems Inc’s upcoming earnings report date is Sep 02, 2026 which is in 43 days.
How were Veeva Systems Inc’s earnings last quarter?
Veeva Systems Inc released its earnings results on Jun 03, 2026. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.139 by $0.101.
Is Veeva Systems Inc overvalued?
According to Wall Street analysts Veeva Systems Inc’s price is currently Undervalued.
Does Veeva Systems Inc pay dividends?
Veeva Systems Inc does not currently pay dividends.
What is Veeva Systems Inc’s EPS estimate?
Veeva Systems Inc’s EPS estimate is 2.22.
How many shares outstanding does Veeva Systems Inc have?
Veeva Systems Inc has 162,443,300 shares outstanding.
What happened to Veeva Systems Inc’s price movement after its last earnings report?
Veeva Systems Inc reported an EPS of $2.24 in its last earnings report, beating expectations of $2.139. Following the earnings report the stock price went down -0.067%.
Which hedge fund is a major shareholder of Veeva Systems Inc?
Currently, no hedge funds are holding shares in VEEV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Veeva Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$238.45 (41.98% Upside)
$238.45 (41.98% Upside)
Blogger Sentiment
Bullish
VEEV Sentiment 75%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 6.9%
Last 30 Days ▲ 6.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.32%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.57%
Trailing 12-Months
Company Description
Veeva Systems Inc
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
VEEV Revenue Breakdown
58.18% North America
27.79% Europe
11.35% APAC
2.68% Middle East, Africa, and Latin America
VEEV Stock 12 Month Forecast
Average Price Target
$238.45
▲(41.98% Upside)
Technical Analysis
Healthequity
―
Doximity
―
GE Healthcare Technologies Inc
―
BrightSpring Health Services, Inc.
―
Tempus AI, Inc. Class A
―
Ownership Overview
1.02% Insiders
23.75% Mutual Funds
1.08% Other Institutional Investors
48.81% Public Companies and Individual Investors